AAM
BMY.RT

Augustine Asset Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Augustine Asset Management’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-34,316
Closed -$24K – 87
2020
Q4 		$24K Sell
34,316
-1,686
-5% -$3.59K 0.01% 83
2020
Q3 		$81K Sell
36,002
-1,625
-4% -$4.64K 0.05% 80
2020
Q2 		$135K Sell
37,627
-522
-1% -$1.88K 0.08% 76
2020
Q1 		$145K Sell
38,149
-190
-0.5% -$626 0.1% 72
2019
Q4 		$115K Buy
+38,339
New +$99.7K 0.07% 73

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Augustine Asset Management's BMY.RT Position: Q1 2021 in Review

Augustine Asset Management sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 34,316 shares — an estimated $24K sold.

Augustine Asset Management first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $145K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Augustine Asset Management reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Augustine Asset Management sold 34,316 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $24K.
  • Augustine Asset Management first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Augustine Asset Management's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $145K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Augustine Asset Management's 13F filing for Q1 2021, filed 5 May 2021.